Form 4: Rocket Pharmaceuticals CEO Sells Shares to Cover Tax Obligations

Rocket Pharmaceuticals CEO, Gaurav Shah, sold 11,091 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Summary

• Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 11,091 shares of common stock on November 21, 2024, at a price of $13.054 per share.
• This sale was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Shah directly owns 707,328 shares of common stock.
• He also indirectly owns 207,897 shares through his spouse and 198,341 shares through the Gaurav D. Shah Irrevocable Trust.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine transaction for tax purposes, and not indicative of any change in the company's prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many executives at comparable biotech companies such as BioMarin, Vertex, and Regeneron regularly file Form 4s for similar transactions.
• The number of shares sold and the price are within the typical range for such transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Rocket Pharmaceuticals, Gaurav Shah, stock sale, insider trading, Form 4, Restricted Stock Units, tax obligations